Post by PPD

The global incidence of melanoma has been rising over the past few decades, making it an increasingly common and significant public health concern. Advances in research and innovation are essential to develop more effective, safer and accessible treatments for melanoma patients worldwide. At a time when acceleration is essential, the PPD™ clinical research business of Thermo Fisher Scientific is the right partner to advance your therapeutic development. We apply our hands-on, global knowledge of medical and operational needs to quickly put your trial on the path to success. Learn more » http://spr.ly/6047BBEQH7